COVID-FIS: Pilot in COVID-19 (SARS-CoV-2) of Fisetin in Older Adults in Nursing Homes

NCT04537299 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

20

Enrollment

OTHER

Sponsor class

Stopped The DSMB and NIA determined the study should be stopped due to futility.

Conditions

Covid19
SARS-CoV Infection

Interventions

DRUG: Fisetin
DRUG: Placebo

Sponsor

Mayo Clinic

Collaborators

[object Object]